Genomictree Inc.
228760.KQFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
2
Cost of Revenue
2
Gross Profit
-1
Gross Margin
-30.8%
Operating Income
-11
Operating Margin
-648.2%
Net Income
-8
Net Margin
-433.6%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
-7
EBITDA Margin
-379.2%
2023
12/31/2023
Revenue
3
Cost of Revenue
3
Gross Profit
-1
Gross Margin
-30.4%
Operating Income
-13
Operating Margin
-506.2%
Net Income
-7
Net Margin
-256.2%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
-5
EBITDA Margin
-183.5%
2022
12/31/2022
Revenue
22
Cost of Revenue
4
Gross Profit
18
Gross Margin
80.5%
Operating Income
2
Operating Margin
8.1%
Net Income
-5
Net Margin
-22.2%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
2
EBITDA Margin
10.1%
2021
12/31/2021
Revenue
4
Cost of Revenue
3
Gross Profit
1
Gross Margin
33.8%
Operating Income
-7
Operating Margin
-191.7%
Net Income
-9
Net Margin
-222.3%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
-4
EBITDA Margin
-112.8%
2020
12/31/2020
Revenue
1
Cost of Revenue
1
Gross Profit
-0
Gross Margin
-49.7%
Operating Income
-9
Operating Margin
-1001.6%
Net Income
-9
Net Margin
-952.1%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
-7
EBITDA Margin
-738.3%